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Abstract 
Kaposi’s Sarcoma-associated Herpesvirus (KSHV) is an oncogenic virus, the etiological agent of 
Kaposi’s Sarcoma (KS) and primary effusion lymphoma (PEL). One of the key viral proteins that 
contributes to tumorigenesis is vFLIP, a viral homologue of the FLICE inhibitory protein. This 
KSHV protein interacts with the NFB pathway to trigger the expression of anti-apoptotic and pro-
inflammatory genes and ultimately leads to tumour formation. The expression of vFLIP is regulated 
at the translational level by an internal ribosomal entry site (IRES) element. However the precise 
mechanism by which ribosomes are recruited internally and the exact location of the IRES has 
remained elusive. Here we show that a 252- nucleotide fragment directly upstream of vFLIP, within 
a coding region, directs translation. We have established its RNA structure and demonstrate that 
IRES activity requires the presence of eIF4A and an intact eIF4G. Furthermore, and unusually for 
an IRES, eIF4E is part of the complex assembled onto the vFLIP IRES to direct translation. These 
molecular interactions define a new paradigm for IRES-mediated translation.  
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Introduction 
Kaposi’s Sarcoma-associated Herpesvirus (KSHV), or Human Herpes Virus 8 (HHV-8) is an 
oncogenic virus and the etiological agent of Kaposi’s Sarcoma (KS) (Chang et al. 1994; Mesri et al. 
2010; Ballon et al. 2011). KSHV is a lymphotropic herpesvirus, containing a large DNA genome 
and inducing latent and lytic phases during infection (Renne et al. 1996; Russo et al. 1996). It 
primarily infects B cells (Ambroziak et al. 1995), but also infects the endothelium and is found in 
spindle cells and cells lining the vessels of KS lesions (Dupin et al. 1999; Colman and Blackbourn 
2008). KS is a multifocal angioproliferative neoplasm and the most common tumour in HIV-
infected patients, where it is a leading cause of mortality and morbidity, their immunodeficiency 
promoting KSHV infection and development of KS (Aversa et al. 2005; Mesri et al. 2010). As a 
result of the HIV pandemic, KS has become one of the most predominant cancers affecting men and 
children in subequatorial African countries; it is seen in 50% of HIV-infected individuals and 
results in a poor prognosis (Parkin 2006). KSHV is also associated with two lymphoproliferative 
diseases, multicentric Castleman’s disease (MCD), a polyclonal lymphoproliferative disorder, and 
primary effusion lymphoma (PEL), an aggressive subtype of non-Hodgkin’s B-cell lymphoma 
(Cesarman et al. 1995; Soulier et al. 1995; Bouvard et al. 2009).  
KSHV infection is mainly latent in KSHV-induced lymphoid tumours (Dupin et al. 1999; Dittmer 
2003). During latency, only a limited subset of genes is expressed encoding proliferative, pro-
angiogenic and anti-apoptotic signals. These latency-associated genes consist of the latency-
associated nuclear antigen (LANA), viral-cyclin (v-cyclin), v-FLICE inhibitory protein (vFLIP) and 
kaposins A, B and C (Dittmer et al. 1998; Jenner et al. 2001; Ganem 2010). vFLIP has been 
proposed to play a role in KSHV pathogenesis by inhibiting FAS-induced apoptosis (Thome et al. 
1997). Recent evidence suggests that the key role of vFLIP is to activate the NF-B pathway by 
interacting with the IB kinase  (IKK) (Chaudhary et al. 1999; Field et al. 2003; Bagneris et al. 
2008). This in turn induces the expression of anti-apoptotic and pro-inflammatory genes (Guasparri 
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et al. 2004; Matta and Chaudhary 2004; Sun et al. 2006), extending the lifespan of infected cells and 
explaining the inflammatory phenotype of KS lesions (Efklidou et al. 2008; Ballon et al. 2011).  
A cluster of latency-associated genes is transcribed from a common promoter encoding consecutive 
open reading frames (ORFs) for LANA (ORF73), vCyclin (ORF72) and vFLIP (ORF71), yielding a 
tricistronic transcript and a bicistronic transcript encoding vCyclin and vFLIP only (Talbot et al. 
1999; Bieleski and Talbot 2001; Pearce et al. 2005). Recently, ribosome profiling studies revealed 
that the transcripts accumulation profiles differ in SLK cells (Arias et al. 2014). During latency only 
the tricistronic transcript LANA-vCyclin-vFLIP is present while the bicistronic transcript vCyclin-
vFLIP could only be detected in lytic SLK cells, confirming that vFLIP is expressed from the 
bicistronic message but that its expression is mainly regulated at the RNA level during latency 
(Arias et al. 2014). However, SLK cell lines are contaminated with renal-cell carcinoma and cannot 
serve as model for KS-derived endothelial tumour cell biology or oncogenesis, nevertheless they 
support KSHV replication and are useful for the study of KSHV gene expression in nonendothelial 
contexts (Sturzl et al. 2013). The absence of a transcript encoding vFLIP alone hinted at a peculiar 
vFLIP expression mechanism and several studies proposed that vFLIP is expressed via a cap-
independent mechanism involving an internal ribosome entry site (IRES) element located within the 
vCyclin coding region (Bieleski and Talbot 2001; Grundhoff and Ganem 2001; Low et al. 2001). 
The majority of cellular mRNAs are translated via a cap-dependent mechanism during which the 5’ 
cap structure of the mRNA is recognized by eukaryotic initiation factor complex 4F (eIF4F), 
comprising eIF4E, eIF4A and eIF4G (Hinnebusch 2014). Then, eIF4F recruits onto the mRNA a 
43S pre-initiation complex consisting of a 40S ribosomal subunit, the ternary complex eIF2-GTP-
MettRNAi, eIF3, eIF1 and eIF1A, thereby priming the canonical scanning mechanism. In contrast, 
several viral mRNAs and some cellular mRNAs initiate translation via a cap-independent 
mechanism in which IRES elements within the mRNA internally recruit the ribosome, bypassing 
the need for many of the eIFs and a 5’ cap recognition event (Jackson et al. 2010). IRES elements 
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have been discovered in the genomes of a number of RNA viruses, mainly within the 5’ 
untranslated region (UTR) of picornaviruses and flaviviruses, and most studies suggest that 
structured RNA domains specifically interact with eIFs or even directly with the ribosome to 
mediate translation (Balvay et al. 2007; Kieft 2008; Plank and Kieft 2012). Unlike most viral IRESs 
discovered to date, the KSHV vFLIP IRES is unusual in that it is located within a DNA virus 
genome, and a coding region, not a 5’UTR. However some controversy remains concerning the 
location of the IRES element and little is known about its function. Studies proposed that the IRES 
resides within the 363 or 232 nucleotides of ORF72 directly upstream of ORF71; while another 
report detected no IRES activity associated with these fragments and suggested that the IRES lies 
within an internal 233 nucleotide fragment of ORF72 (Bieleski and Talbot 2001; Grundhoff and 
Ganem 2001; Low et al. 2001). To address those discrepancies and understand how the vFLIP IRES 
controls translation we redefined the vFLIP IRES boundaries both in the in vitro rabbit reticulocyte 
lysate (RRL) model system, and in 293 cells, identifying a 252- nucleotide IRES upstream of the 
vFLIP ORF. Subsequently, we characterized its functional requirement and demonstrate that vFLIP 
IRES activity requires the presence eIF4A, an intact eIF4G, but also eIF4E, and that these factors 
are part of the complex assembled onto the vFLIP IRES. This requirement for the entire eIF4F 
complex is unprecedented. Furthermore, we characterized the RNA structure of the IRES domain in 
solution revealing a compact RNA scaffold.   
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Results 
Identification of a minimal IRES domain 
Previous reports suggested the presence of an IRES element within the vCyclin coding region 
driving vFLIP expression (Figure 1A). First, using bicistronic luciferase reporter constructs in SLK 
cells, a minimal IRES was identified within the 232 nucleotides located upstream of ORF71 
(Grundhoff and Ganem 2001). However in BCP-1 cells, no IRES activity could be detected for this 
fragment and bicistronic luciferase reporter constructs suggested instead that the IRES activity lay 
within an internal 233- nucleotide fragment (Bieleski and Talbot 2001). Moreover in 293 cells and 
using bicistronic reporter constructs, the IRES activity was assigned to the 363 nucleotides directly 
upstream of ORF71, for which no IRES activity was found in BCP-1 cells (Low et al. 2001). In 
order to resolve these discrepancies, we set out to delineate the minimal sequence required for IRES 
activity in the in vitro RRL model system. First, the following plasmids were first assayed in in 
vitro translation reactions in RRL: the bicistronic reporter plasmid containing the 856 nucleotides 
comprising of ORF72 and the intergenic region, inserted between the CAT and LUC open reading 
frames (pGEM-CAT/vFLIP IRES/LUC; lane 7), the negative-control plasmid lacking any IRES 
sequence (pGEM-CAT/LUC; lane 1), and the bicistronic plasmid, pGEM-CAT/EMCV/LUC (lane 
2), containing the EMCV IRES as a positive control, (Figure 1A and 1B). SDS-PAGE and 
autoradiography for CAT and LUC expression showed that all plasmids efficiently expressed CAT, 
as expected (Figure 1B). Furthermore, the EMCV IRES directed efficient LUC expression; in 
addition the 856 nucleotides upstream of ORF71 display IRES activity, as indicated by LUC 
expression (Figure 1B; lane 1, 2 and 7). To further define the minimal sequence required for IRES 
activity we systematically shortened the 856 sequence, to generate 658, 363, 252 nucleotides 
fragments as indicated on figure 1A, and assessed the ability of truncated sequences to promote 
IRES activity. We identified a minimal domain of 252 nucleotides supporting IRES activity (Figure 
1B; lane 4), and shortening this domain further to 189 nucleotides abolished IRES activity 
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(Supplementary Figure 1A). However, no LUC expression could be detected when we used the 
previously identified internal 233 nucleotides fragments to drive IRES activity (Figure 1B; lane 3). 
Furthermore, adding a stable stem-loop directly upstream of the 252 nucleotides IRES (SL-252) had 
no impact on internal initiation, supporting its role as an IRES (Figure 1C). To support these data, 
we investigated the activity of the vFLIP IRES in 293 cells (Figure 1D). To this end, the 252- 
nucleotide vFLIP (pRF-252), EMCV (pRF-EMCV) and c-myc (pRF-cmyc) IRESs were inserted in 
the intergenic region of a bicistronic pGL3 plasmid between the renilla luciferase (rLUC) and 
firefly luciferase (fLUC) open reading frames (Stoneley et al. 2000). The resulting plasmids were 
transfected into 293 cells and the expression from both renilla and firefly luciferase cistrons was 
assayed (Supplementary Figure 1B). The integrity of the transcripts produced from bicistronic 
reporter plasmids was verified at the end of the reaction to ensure that firefly luciferase reflected 
IRES activity using RT-PCR and Northern blotting as described previously (Van Eden et al. 2004), 
and only one product was detected (data not shown). Subsequently, the IRES activity was expressed 
as the ratio of fLUC to rLUC normalized to the empty plasmid (pRF). The positive controls EMCV 
and c-myc IRES directed efficient internal initiation of translation, although the well-characterized 
EMCV IRES was less efficient than the cellular c-myc IRES (5.4 versus 28.4 relative IRES 
activity). In agreement with our in vitro translation results the 252- nucleotide vFLIP IRES was able 
to support IRES activity (10.4 relative IRES activity, Figure 1E). Furthermore, we also investigated 
the IRES activity of the vFLIP IRES in SLK cells, which support KSHV replication, but do not 
represent a model for KS (Herndier and Ganem 2001; Sturzl et al. 2013). While we could not detect 
EMCV IRES activity above background in those cells, the positive control pRF-cmyc IRES and the 
pRF-252 both displayed IRES activity, confirming our previous results (Supplementary Figure 1C). 
These results suggest that the optimally effective IRES element lies within the 252 nucleotides 
directly upstream of ORF71. 
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vFLIP IRES activity requires intact eIF4G and eIF4A 
To date the study of vFLIP IRES activity has been limited to delineating the IRES domain and 
assessing its interaction with a general ITAF, PTB (Bieleski et al. 2004). To evaluate the 
contribution of specific eukaryotic initiation factors in vFLIP-mediated translation we used the in 
vitro RRL translation system in combination with chemical and protein inhibitors of translation. 
First, we investigated the functional role of eIF4F components. While eIF4F, composed of eIF4A, 
eIF4G and eIF4E, is strictly required for cap-dependent translation, some IRESs can function either 
in the absence of eIF4F or in the presence of a subset of the complex (Balvay et al. 2009). For 
example, IRES elements from picornaviruses function in the presence of only eIF4A and a cleaved 
fragment of eIF4G (Pause et al. 1994; Pestova et al. 1996; de Breyne et al. 2009; Yu et al. 2011). 
During infection, the poliovirus (PV) 2A protease and the foot and mouth disease virus (FMDV) L 
protease each inhibit cap-dependent translation by inducing the cleavage of eIF4G, separating the 
eIF4E interacting domain (Gingras et al. 1999), while the resulting eIF4G C-terminus domain can 
still support IRES-mediated translation (Balvay et al. 2009; Jackson et al. 2010). To investigate the 
role of eIF4G in vFLIP IRES activity, we analysed the effect of its cleavage in the in vitro RRL 
translation reactions using the bicistronic pGEM-CAT/LUC reporters used to define the minimal 
IRES domain. Adding L-protease to the RRL induced a specific eIF4G cleavage as previously 
described (Supplementary Figure 2A) (Ohlmann et al. 1996). The bicistronic plasmids were assayed 
in RRL in the presence and absence of FMDV L-protease. As expected the FMDV L-protease 
severely reduced translation of the first upstream CAT cistron, while the translation of the LUC 
cistron controlled by the EMCV IRES, which can function in the presence of the cleaved eIF4G 
fragment, was not affected (Figure 2A). However, when placed under the control of the vFLIP 
IRES the translation of the LUC cistron was impaired by the addition of FMDV L-protease (Figure 
2A). These results suggest than an intact eIF4G, including the N-terminal domain mediating the 
interaction with eIF4E, is required for vFLIP dependent IRES activity.  
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We then investigated whether eIF4A was also involved. To evaluate the requirement for eIF4A, we 
used hippuristanol a natural compound that binds the C-terminal region of eIF4A and thus inhibits 
its RNA binding, helicase and ATPase activities (Bordeleau et al. 2006). Addition of 1M 
hippuristanol inhibits the translation of both the control EMCV IRES-driven luciferase and the 
vFLIP IRES-driven luciferase suggesting a functional requirement for eIF4A (Figure 2B). In 
contrast, the addition of hippuristanol has no effect on IRES activity driven by the HCV IRES 
which does not require eIF4A activity for translation (Supplementary Figure 2B). 
 
Inactivation of eIF4E inhibits vFLIP IRES activity 
The requirement of the eIF4E interacting domain of eIF4G for vFLIP IRES activity prompted us to 
investigate whether eIF4E and the eIF4E-eIF4G interaction are required as well. First we assessed 
the role of the eIF4G:eIF4E interaction using 4EGI-1, a previously described inhibitor of the 
eIF4E:eIF4G interaction (Moerke et al. 2007). While concentrations of up to 50 M of the inhibitor 
did not affect the efficiency of the EMCV or HCV IRES-driven translation, both the cap dependent 
translation, as expected, but also the vFLIP IRES activity were impaired (Figure 3A and 
Supplementary Figure 2B). This suggests that the vFLIP IRES activity depends on the eIF4E-eIF4G 
interaction. Although it is widely used to characterize IRES activity, a recent report proposed that 
4EGI-1 could also inhibit the translation mediated by IRES elements that do not require the eIF4E-
eIF4G interaction (Redondo et al. 2013). Therefore, to confirm our results, we performed similar 
experiments using 4E1RCat, another compound identified by high throughput screening for 
inhibitors of the eIF4E-eIF4G interaction (Cencic et al. 2011). 4E1RCat blocks cap-dependent 
translation but does not impair translation mediated by the EMCV IRES, which does not require the 
eIF4E-eIF4G interaction (Cencic et al. 2011). As shown previously, adding increasing amounts of 
4E1RCat inhibited the cap-dependent production of CAT (Figure 3B). A dose-dependent inhibition 
of the LUC expression could be also be detected for LUC cistron placed under the control of the 
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vFLIP IRES (Figure 3B). However, the addition of 4E1RCat has no effect on translation driven by 
the HCV IRES, which does not require eIF4E or eIF4G activity (Supplementary Figure 2B). 
Therefore these results confirmed that the vFLIP IRES activity is sensitive to inhibition of the 
eIF4G-eIF4E interaction. To further determine whether the vFLIP IRES-eIF4E interaction plays a 
significant role for IRES activity, translation efficiency was examined in RRL treated with the cap 
analogue m7GpppG to impair eIF4E function (Merrick 2004). As expected, the addition of 
increasing amounts of cap analogue impaired the translation of the CAT upstream cistron, inhibiting 
cap dependent translation, while the activity of the EMCV IRES was unaffected (Figure 3C). 
However, and surprisingly for an IRES, the activity of the vFLIP IRES displayed a dose-dependent 
inhibition response to the addition of the cap analogue (Figure 3C). All these results strongly 
suggest that functional eIF4E and the eIF4E binding domain of eIF4G are required for the internal 
entry of ribosomes mediated by the vFLIP IRES.  
 
eIFs are recruited onto the vFLIP IRES 
Taken together these results indicate that the vFLIP IRES requires the whole eIF4F complex for its 
activity, including eIF4E, and therefore it could interact with the IRES either directly, or indirectly 
through eIF4G. To further probe the eIF requirements of the vFLIP IRES for the eIF4F complex we 
investigated whether eIF4E and eIF4G could bind to the vFLIP IRES in vitro. The fragment 
encoding the 252 nucleotide IRES, or an antisense control, were inserted into the pSP64 Poly(A) 
transcription vector. Following linearization of these plasmids, RNA transcripts corresponding to 
the vFLIP IRES with a 30-nt poly(A) stretch added to its 5’ end, were generated in vitro. These 
transcripts were then immobilized on oligo-dT magnetic beads as previously described 
(Stassinopoulos and Belsham 2001). The presence of the poly(A) stretch at the 5’ extremity 
prevented non-specific eIF recruitment via the 5’ end. Then, to monitor the association of eIFs with 
the vFLIP IRES, RRL was incubated with the beads-RNA complexes. After washing, the bound 
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proteins were separated by PAGE and analyzed by immunoblotting. As shown in Figure 4A both 
eIF4G and eIF4E form a complex assembled onto the vFLIP IRES but not on the antisense control, 
although minor eIF4E binding was detected. To ensure that the recruitment of eIF4E could not 
occur from the 5’end of the RNA reporter, we repeated the experiment with RNA capped with a 
non-functional cap analogue to block the 5’end; and we observed similar results (data not shown). 
To further confirm that eIF4E and eIF4G are part of the complex assembled onto the vFLIP IRES 
we applied a methodology previously developed to isolate IRES-bound translation complexes 
(Boehringer et al. 2005; Locker et al. 2006). Briefly, hybrid RNA containing the vFLIP IRES or the 
HCV IRES, as a control, and the tobramycin aptamer were generated by in vitro transcription. 
Hybrid RNAs were then incubated in RRL in the presence of GMP-PNP to assemble initiation 
complexes, which were then isolated by affinity chromatography using tobramycin-coupled 
sepharose. Following elution of the complexes, the presence of initiation factors was analyzed by 
Western blotting. As expected and in agreement with previous studies (Locker et al. 2007), 
complexes assembled onto the HCV IRES contained eIF3 but not eIF4E or eIF4G (Figure 4B). 
However, the complexes assembled onto the vFLIP IRES contained eIF3, eIF4E and eIF4G (Figure 
4B). Therefore these results confirm our previous results and suggest that both eIF4G and eIF4E are 
part of the complex assembled onto the vFLIP IRES that mediate IRES activity.   
 
vFLIP IRES directly interact with the ribosomes and eIFs.  
To identify the interactions between the translation machinery and the vFLIP IRES and their 
contribution to 48S complex formation, we assayed whether individual initiation factors or the 40S 
ribosomal subunit could directly interact with the IRES. Therefore, eIFs and ribosomal subunits 
were purified from HeLa cells according to described procedures (Pisarev et al. 2007). Then, 
individual purified components were incubated with 32P-labeled vFLIP IRES before conducting 
filter binding assays to analyze the affinity and specificity of putative interactions (Willcocks et al. 
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2011). We determined that the vFLIP IRES binds the 40S subunit with an apparent equilibrium 
dissociation constant (Kd) of 28nM, while the CSFV IRES (as a control) bound with an affinity of 8 
nM (Figure 5A). This shows that the vFLIP IRES can bind directly to the 40S subunit in the 
absence of any initiation factor, a property in common with HCV-like and dicistrovirus IRESs, 
supporting its function as an IRES. Furthermore, the vFLIP IRES also binds to eIF3 with an affinity 
of 8 nM (Figure 5B). In contrast, no specific interactions could be detected between the vFLIP  
IRES and eIF4E (Figure 5C). While it was not possible to obtain sufficient yield of intact full-
length eIF4G or the entire eIF4F complex from HeLa cytoplasmic extract, it was possible to obtain 
the eIF4A/p100 complex (p100 corresponding to the cleaved fragment of eIF4G that lacks the 
eIF4E binding site). Again, we could not detect any direct interaction between eIF4A/p100 and 
vFLIP IRES while it binds the EMCV IRES as previously proposed (Figure 5C). These results 
suggest that an intact eIF4G is important for the assembly of the initiation complex onto the vFLIP 
IRES. To support this we repeated the oligo-dT pull down experiment in the presence of the FMDV 
L-protease and showed that eIF4G cleavage abolished eIF4E and eIF4G recruitment to the vFLIP 
IRES (Figure 5D).  Therefore, we propose that the intact eIF4F complex interacts with the vFLIP 
IRES rather than its individual components.    
 
Determination of the vFLIP IRES structure 
Most viral IRES elements contain structured RNA domains that are crucial for IRES function by 
interacting with eIFs or the ribosome. For example, within the HCV IRES, domain III stem-loops 
coordinate small ribosomal subunit recruitment, while we previously demonstrated that a loop 
structure within domain II mediates the 60S subunit joining event (Locker et al. 2007). Therefore a 
deep understanding of the structures accessible to RNA is required to decipher IRES-mediated 
regulation during translation. To further characterize the vFLIP IRES we analysed its structure in 
solution using Selective 2′ Hydroxyl Acylation analysis by Primer Extension (SHAPE), chemical 
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and enzymatic probes. SHAPE analysis interrogates the RNA backbone flexibility at single-
nucleotide resolution as flexible nucleotides can sample local conformations increasing the 
nucleophilic reactivity of 2'-hydroxyl groups toward 1M7 (Mortimer and Weeks 2007). The sites of 
modification were then mapped as stops by primer extension reaction, followed by capillary 
electrophoresis analysis, allowing us to assign quantitative SHAPE reactivity to individual 
nucleotides (Supplementary Figure 4). The SHAPE studies were repeated three times and the mean 
of reactivity for each position was used to model the IRES structure in combination with 
accessibility information yielded by other chemical and enzymatic probes such as RNAse V1 
reactivity, to detect double stranded regions, CMCT and DMS reactivity, to detect single stranded 
regions (Figure 6). The SHAPE data were then used as constraints for “RNA structure” an RNA 
secondary structure prediction software implemented with the “shapeknot module” (Bellaousov et 
al. 2013; Hajdin et al. 2013). The different models obtained were evaluated for consistency with the 
V1, DMS and CMCT data. The model that best fits all the data is shown on Figure 6. In only a very 
few places the model is in conflict with the reactivity data, which may reflect the formation of a 
tertiary structure, for which we could not identify any constraints. Most V1 hits are in helical 
region, but a few are found in loops (Id, II and IV), which could reflect the formation of tertiary 
structure or local non canonical base pairs, yet to be identified. Furthermore, “shapeknot” 
highlighted a potential “kissing complex” by pairing dII 5’-171GCUUGUG177-3’ with dIV 5’-
239UACAAGC245-3’. Although we have no further evidence to support such interaction, this would 
be in agreement with the ambivalent nature of probing reactivities observed in this region, as shown 
by weak SHAPE reactivity, the CMCT and DMS hits and the few RNAse V1 hits observed. 
Overall, most DMS and CMCT hits are in single stranded region or at the edges of helices, only the 
hits in the 3’ region of domain II challenges our model. They may reflect the breathing of a helix 
that comprises mainly A-U and G-U base pairs. Some positions are reactive to DMS or CMCT, but 
not to 1M7 (G58 or U180 for example), this is not necessarily a discrepancy since DMS and CMCT 
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probe the involvement of the Watson-Crick position in hydrogen bonds, while 1M7 probes the 
flexibility of the ribose. Thus, nucleotides constrained by non-canonical interactions not involving 
Watson-Crick positions are predicted to be unreactive towards 1M7, but may be reactive to DMS or 
CMCT. 
The vFLIP IRES adopts a compact structure, which is largely reflected by the overall low SHAPE 
reactivity. Two main domains can be identified, the first corresponding to nucleotides 1 to 154, 
while the second consists of 155 to 252 nucleotides. The first part of the IRES structure is formed 
by domain I which consists of subdomains Ia to If organized into two consecutive junctions: a four-
helix junction made of Ia, Ib, Ie and If, followed by a three-helix junction made of Ib, Ic and Id. 
Domains Ic and Id are capped by a UCGG and a GGCA tetraloop, respectively; while domain Ie 
and If are capped by CUACA and CCUAAC loops, respectively. The second part of the IRES 
structure consists of three stem-loop structures, domains II, III and IV. This part of the structure 
provides an attractive platform for protein recruitment as domain II and IV are capped by large 
loops consisting of 17 and 16 nucleotides, respectively, while domain III is capped by a pyrimidine-
rich (U4C2) loop.  
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Discussion 
Previous studies have suggested that expression of vFLIP, a key KSHV tumorigenesis factor during 
latency, is mediated by an IRES element (Bieleski and Talbot 2001; Grundhoff and Ganem 2001; 
Low et al. 2001). Adding to the controversy surrounding its exact location with different studies in 
cells or in vitro defining different domains for internal entry, the vFLIP IRES is atypical in nature, 
being located in the coding region of a DNA virus, while most viral IRESs characterized so far are 
located in the 5’ UTR of positive sense RNA viruses. Therefore, its presence hinted at a molecular 
mechanism mediating internal entry of ribosomes that is specific to the KHSV IRES.  
To reconcile previous studies, and to establish the boundaries of the vFLIP IRES, different plasmid 
constructs were generated containing a decreasing length of the terminal vCyclin coding region, and 
included the previously identified 233-nucleotide minimal IRES domain. First, we defined a 
minimal 252-nucleotide vFLIP IRES in vitro using a translation assay in RRL. Subsequently, the 
ability of this segment to direct translation was confirmed in 293 and SLK cells - which have been 
extensively used in the past to characterize KSHV gene expression, but do not represent a KS 
model system (Herndier and Ganem 2001; Sturzl et al. 2013). Furthermore, we showed that this 
RNA fragment can directly recruit the ribosome subunit with nanomolar affinity, a property shared 
with other IRES (Kieft 2008). 
To characterise of its mode of action, we then dissected which initiation factors are required for 
IRES activity using a variety of specific inhibitors of translation. As the IRES activity is sensitive to 
the addition of both hippuristanol and the FMDV L-protease, we concluded that both eIF4A and an 
intact eIF4G are required for cap-independent translation. While the C-terminal domain of eIF4G 
interacts with eIF4A and eIF3 to recruit the ribosome, the N-terminal domain cleaved by the L-
protease is responsible for eIF4E interaction and holding the eIF4F complex together. Therefore, we 
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further assessed whether eIF4E and the eIF4E:eIF4G interaction played a role in vFLIP IRES-
mediated translation. Using inhibitors of the eIF4E:eIF4G interaction, we established that this 
interaction is critical to mediate vFLIP IRES activity. These findings were supported by further 
studies demonstrating that the addition of a cap analogue, to inactivate eIF4E, also impaired vFLIP 
IRES activity. Altogether, these results suggest that not only eIF4G and eIF4A, but also eIF4E are 
required for vFLIP IRES activity. As the requirement for eIF4E seemed unusual for a mechanism of 
ribosome internal entry, we further analysed the association of the core initiation factors eIF4G and 
eIF4E with either isolated vFLIP IRES or within initiation complexes. We found that eIF4G can 
associate with the vFLIP IRES but also that eIF4E interacts with the vFLIP IRES during translation 
initiation, which is unprecedented for an IRES to our knowledge. Those results support a mode of 
action in which both eIF4E and intact eIF4G are involved in tethering ribosomes to the vFLIP IRES 
to direct translation. We could not detect any direct interaction with isolated eIF4E and the 
eIF4A/p100 complex, this leads us to propose that the intact eIF4F is recruited to the vFLIP IRES, 
and that this is likely to be through the direct interaction between the IRES, the 40S subunit and 
eIF3. These results also suggest that viral IRES display a much larger functional requirement than 
those used to define the four groups of IRES elements. Indeed while the functional requirement for 
eIF4A and the interaction with eIF4G, could be reminiscent of type I and type II IRESs, such as PV 
or EMCV IRESs respectively, these IRESs are able to function in the presence of a cleaved eIF4G, 
unlike the vFLIP IRES (Yu et al. 2011; Sweeney et al. 2014). Lentiviral gag IRESs also require 
eIF4A activity and form initiation complexes that comprises eIF4A and eIF4G, but do not interact 
directly with eIF4G, nor require the eIF4G-eIF4E interaction (Chamond et al. 2010; Locker et al. 
2011). Meanwhile, the ability to interact directly with the 40S subunit and eIF3 is a property shared 
with HCV-like and primate lentiviruses IRESs (Lukavsky 2009; Locker et al. 2011) 
Most viral IRESs adopt complex RNA structures that coordinate the recruitment of the ribosome 
and initiation factors (Kieft 2008). We therefore established a model of the vFLIP IRES structure 
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using SHAPE analysis combined with traditional modification using chemical and enzymatic 
probes (Figure 5). Probing in solution revealed a very compact structure which is the hallmark of 
many viral IRESs, reflected in the overall poor reactivity towards the single strand specific probes. 
This finding is also in agreement with the presence of two stretches of nucleotides (82-95 and 223-
233) in which we repeatedly observed strong reverse transcription stops reflecting the presence of a 
structure that the reverse transcriptase is unable to resolve. The vFLIP IRES structure scaffold is 
separated into two domains, consisting of domain Ia to If and domain II to domain IV, respectively 
(Figure 5). The data strongly suggest that elements of the modular structures could be involved in 
direct interaction with the ribosome, initiation factors or ITAFs, and further studies should aim at 
characterising the structure-function relationship of the vFLIP IRES.  
IRES elements are by their nature cap-independent, so the requirement for eIF4E here is intriguing. 
Previously the Hepatitis A virus (HAV) IRES also displayed particular eIFs requirement. It was 
proposed that HAV IRES activity could require an interaction between the eIF4E cap binding 
pocket and the IRES or that the eIF4E-eIF4G interaction was necessary for eIF4G to adopt a 
conformation promoting IRES activity, independently from RNA binding by the cap-binding 
pocket (Ali et al. 2001; Borman et al. 2001). However recent findings suggest that the IRES activity 
is stimulated following eIF4G cleavage by the L-protease in cells and therefore the exact initiation 
factor requirement for HAV IRES activity remains unclear (Redondo et al. 2012). In addition we 
cannot rule out a more direct role for eIF4E in cap-independent translation. Several positive-sense 
RNA plant viruses lack a 5’ cap structure and rely on cap-independent translation elements 
(CITEs), located in 3’UTRs, to mediate translation (Nicholson and White 2011). CITEs are highly 
folded RNA structures that recruit initiation factors to the viral RNA and engage in long-range 
RNA-RNA base pairing between the 3’ and 5’UTR to direct translation (Nicholson and White 
2011; Kraft et al. 2013). For example, the pea enation mosaic virus RNA 2 translation element 
(PTE) contains a pseudoknot that binds to eIF4E with high affinity to recruit eIF4F and act as a 
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translation enhancer (Wang et al. 2009). SHAPE analysis and 3D modelling further showed that the 
cap-binding pocket of eIF4E clamps the PTE pseudoknot in the place of the canonical cap (Wang et 
al. 2011). Finally, the ORF of histone H4 mRNA contains a regulatory RNA element that promotes 
translation by recruiting eIF4E, and eIF4F, internally and independently from the cap (Martin et al. 
2011). The direct binding of eIF4E allows the recruitment of eIF4G and eIF4A onto the mRNA 
while another structural element hinders the 5’cap. The 5’ cap is subsequently made available to 
eIF4E through a structural rearrangement mediated by eIF4A (Martin et al. 2011). However, our 
finding that eIF4E cannot bind the vFLIP IRES in the absence of other factors would indicate 
another mechanism of translation. Recently, eIF4E was shown to exercise an unexpected second 
function in translation initiation by stimulating eukaryotic initiation factor 4A helicase activity 
(Feoktistova et al. 2013). Importantly, it was demonstrated that the eIF4E-mediated eIF4A activity 
promotes mRNA restructuring independently from its cap-binding function (Feoktistova et al. 
2013). This new function of eIF4E could explain how eIF4E can selectively stimulate the 
translation of mRNAs that possess a structured 5’UTR, which could apply to IRES elements such 
as HAV or vFLIP IRESs and would support our results. Therefore eIF4E is involved in different 
non-canonical initiation events and its role in KSHV IRES-mediated translation emphasises even 
further the fact it can act beyond its cap-binding activity to mediate translation. This could reflect a 
more general mechanism of initiation by which RNA elements, including the vFLIP IRES, can 
tether eIF4E and eIF4F to mRNA internally to recruit ribosomes and initiate translation.  
Much effort has been dedicated to the development of drugs that could impair IRES-mediated 
translation as a means of blocking viral replication, mainly focusing on the HCV IRES (Dibrov et 
al. 2012; Dibrov et al. 2014). Recently it has been proposed that cap-independent expression of 
vFLIP could provide a mechanism to control the balance between vCyclin and vFLIP levels, 
thereby allowing vFLIP to suppress autophagy and inhibit senescence during latent infection 
(Leidal et al. 2012). By unravelling the molecular mechanism by which the vFLIP IRES directs 
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translation and the RNA structure involved, we reveal a new potential target in the design of drugs 
that could prevent the oncogenic properties of KSHV. 
Materials and Methods 
Cell lines 
SLK cells were maintained in Roswell Park Memorial Institute 1640 medium (RPMI 1640) 
supplemented with 1% penicillin/streptomycin, 1% L-glutamine and 10% foetal bovine serum 
(FBS). 293 cells were maintained in Dulbecco’s modified Eagle’s MEM supplemented with 1% 
penicillin/streptomycin, 1% non-essential amino acids and 1% L-glutamine and 10% FBS. The cells 
were cultured at 37°C in an atmosphere of 5% CO2. 
Plasmids 
To generate the bicistronic constructs, fragments encoding the different IRES sequences were 
amplified by PCR from a genomic fragment corresponding to the second exon of the bicistronic 
ORF72/71 mRNA (Genbank U75698). The c-myc IRES was kindly provided by Anne E Willis 
(MRC Toxicology Unit, University of Leicester, United Kingdom) and the IRES sequence from 
encephalomyocarditis (EMCV, nucleotides 406–930) and hepatitis C virus (HCV; nucleotides 1–
426) were described before (Easton et al. 2009). For in vitro translation, the IRES fragments were 
cloned into the pGEM-CAT/LUC plasmid described previously which encodes chloramphenicol 
acetyltransferase (CAT) and firefly luciferase (fLUC) under the control of a T7 promoter 
(Willcocks et al. 2011). The sequence of the stemloop sequence inserted upstream of the IRES is 5’-
CAGATCTACGCGGTTCGCCGCGTAGATCTG-3’. The constructs were confirmed by restriction 
enzyme digestion, PCR and sequencing. For transfection into cells and luciferase assays, the IRES 
fragments were cloned into the pGL3-rLUC/fLUC plasmid described previously which encode 
Renilla luciferase (rLUC) and firefly luciferase (fLUC) under the control of an SV40 promoter 
(Stoneley et al. 2000).  
Transfections and luciferase assays 
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Transient DNA transfections of SLK and 293 cells was performed in 35 mm dishes using 4 L 
FuGENE HD transfection reagent (Promega) and 2 g of plasmid DNA according to the 
manufacturer’s instructions. The cells were harvested 28 h post transfection. The sample cell lysates 
were frozen and thawed twice before assaying for luciferase activity using the Dual-luciferase 
Reporter assay system (Promega) and detection in a luminometer (Labtech). To check that the 
firefly luciferase activity originated from IRES activity rather than aberrant splicing events or 
cryptic promotor activity, total RNA was extracted from cells and analysed by RT-PCR as 
described by Van Eden et al (Van Eden et al. 2004), and by Northern blotting as described by 
Bushell et al (Bushell et al. 2006). 
In vitro transcription and translation 
In vitro synthesis and purification of capped RNA was carried out using the mMESSAGE 
mMACHINE kit (Ambion) according to the manufacturer’s instructions. The bicistronic reporter 
RNAs (0.5g) were translated in the rabbit reticulocyte lysate (RRL; Flexi RRL system; Promega; 
3.2 mM endogenous Mg2+) in the presence of 20 µM amino acids (lacking methionine), 0.5 mM 
MgOAc2, 100 mM KCl, 0.8 U/µl of RNasin® Plus RNase Inhibitor (Promega) and 0.6 mCi/ml 
[35S]-methionine. Translation reactions, in a final reaction volume of 12.5 µl, were incubated for 
90 min at 30°C. Products were analysed by SDS-PAGE and autoradiography. For inhibition 
experiments, RRL lysates were treated with various concentrations of hippuristanol (kind gift of 
Jerry Pelletier, McGill University Canada), 4E1RCat (idem), L-Protease (kind gift of Simon J 
Morley, University of Sussex, United Kingdom), 4EGI-1 (Merck), cap analogue m7GpppG 
(Ambion) or 5% DMSO as control.  
Luciferase assays 
RNA affinity chromatography 
The IRES fragments were cloned into the pSP64 poly(A) plasmid (Promega) using standard 
techniques. Subsequently RNAs were in vitro transcribed and purified using the MEGAscript T7 kit 
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(Ambion) with or without the addition of ApppG (New England Biolabs). The transcripts were then 
immobilized onto oligo-dT magnetic beads (Life Technologies) and incubated with RRL (5 g) as 
previously described (Stassinopoulos and Belsham 2001). The bound proteins were washed, eluted 
in 2X SDS sample buffer and separated by SDS-PAGE electrophoresis. Proteins were then 
transferred onto PVDF membrane and detected using antibodies against eIF4E and eIF4G (kind gift 
of Simon J. Morley, University of Sussex, United Kingdom). 
For translation complex analyses, the IRESs were evaluated using tobramycin affinity purification 
(Hartmuth et al. 2002). Briefly, the IRES fragments were cloned into a pUC18 plasmid between a 
T7 promoter and the tobramycin aptamer sequence using standard protocols. The RNAs were then 
transcribed using the MEGAscript T7 kit (Ambion) and purified as described (Sargueil et al. 2000). 
Affinity purification of translation complexes assembled in RRL in the presence of 5 mM GMP-
PNP was then performed as previously described (Boehringer et al. 2005) and the presence of 
individual eIFs assayed by immunoblotting using antibodies against eIF3f (Santacruz; sc-28856) 
and rpS6 (Santacruz; sc-4426).  
Filter binding assays 
The filter binding assays were performed as described before without modification (Willcocks et al. 
2011). Control RNA encoding the CSFV IRES (1-427; Paderborn strain) was generated by standard 
molecular cloning using a bicistronic plasmid containing the CSFV IRES (kind gift of Graham 
Belsham; National Veterinary Institute; Lindholm, Denmark). Briefly vFLIP, CSFV or EMCV 
RNA transcripts were transcribed in vitro in the presence of -32P-UTP (3,000 mCi/mmol). The 
40S ribosomal subunits and eIF3 were prepared following previously established procedures from 
HeLa cells (Pisarev et al. 2007). eIF4E, eIF4A and eIF4G-p100 were expressed as recombinant 
proteins in E. coli using the following plasmids: pET16-eIF4A (kind gift of Dr Frank Martin, 
Université de Strasbourg), pGEX-eIF4E (kind gift of Dr Theophile Ohlmann, ENS Lyon) and 
pET22-p100. Radiolabeled RNA (50 fmol) incubated was with serial dilutions of initiation factors 
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(eIFs) or 40S subunit in binding buffer (20 mM Tris [pH 7.6], 100 mM KCl, 2 mM DTT, 2 mM 
MgCl2) and incubated at 37°C for 15 min before performing filter binding assays. Bound RNA was 
quantified using a Typhoon FLA7000 (GE Healthcare). To determine the apparent dissociation 
constant (Kd), the data were fitted to a Langmuir isotherm described by the equation = P/(P +Kd), 
where  is the fraction of RNA bound and P is either the 40S subunit or eIF concentration. Reported 
values are the average of results from three repetitions with standard errors. All calculations were 
performed with GraphPad Prism 7. 
RNA structure determination 
The secondary structure of the KSHV IRES was probed using dimethyl sulphate (DMS), N-
cyclohexyl-N’-[N-methylmorpholinoethyl]-carbodiimid-4-toluenesulfonate (CMCT) and RNAse 
V1 and analysed by reverse extension as described previously (James and Sargueil 2008; Weill et 
al. 2010; Willcocks et al. 2011). RNA Selective 2′ Hydroxyl Acylation analysis by Primer 
Extension (SHAPE) analysis was conducted using 1-methyl-7-nitroisatoic anhydride (1M7) as a 
modifying agent as previously described (Mortimer and Weeks 2007; Deforges et al. 2012). 
Modifications were revealed using RNAse H− M-MLV RT (Promega) and primers labelled with 
WellRed D2, D4 (Sigma-aldrich), or IR-800 (MWG Eurofins) fluorophores, cDNA fragments were 
resolved by capillary electrophoresis (Beckman Coulter CEQ 8000). Data were then interpreted and 
analyzed using the software ‘QuSHAPE’ (Karabiber et al. 2013) (http://bioinfo.unc.edu). 
The reverse transcription reactions were performed using the following primers: 5’-
ACAGCTATGACCATGATTACGA-3’, 5’-TCCACCCTAAACAAAATCAC-3’, 5’-
ACCTCGCTATACTAAGCC-3’, 5’-GTTTCCGTTCTACAGGCGG-3’, 5’-
CGGACTTTGATCTGCGCA-3’, 5’-TTGTGATTTTGTTTAGGGTG-3’ 
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Supplementary information is available for this manuscript. 
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Figure Legends 
Figure 1. Assessment of IRES activity in Rabbit Reticulocyte Lysate and 293 cells. (A) Schematic 
representation of the bicistronic mRNAs used. The indicated fragments from the vCyclin-vFLIP 
mRNA were cloned between the CAT and LUC ORFs, and previously identified IRES are 
highlighted. (B) and (C) In vitro transcribed capped bicistronic mRNAs were translated in RRL 
containing 35S Methionine and reactions analysed by SDS-PAGE and autoradiography. The CAT 
and LUC products are indicated. The results are representative from three independent experiments. 
(D) Schematic representation of the bicistronic mRNAs used, the indicated IRESs were inserted 
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between the rLUC and fLUC reporters genes as described in Material and Methods. (E) 293 cells 
were transfected with bicistronic reporter plasmids as indicated. Rluc and Fluc activities were 
measured as described in the Material and Methods section. The relative Fluc/Rluc ration was set to 
1 for the empty pRF plasmid as relative IRES activity. Values are the mean +/- SEM from three 
independent experiments and were analysed by one-way ANOVA with Dunnett’s multiple 
comparison test: * P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 (GraphPad Prism 6.0)  
Figure 2. vFLIP IRES activity requires intact eIF4G and eIF4A. Bicistronic capped mRNAs, in the 
form of CAT/IRES/LUC were translated in vitro in RRL, pretreated with FMDV L-protease (L-pro) 
as indicated (A), or in the presence (+) or absence (-) of the eIF4A inhibitor hippuristanol (B). The 
CAT and LUC products are indicated. The data shown are representative from three independent 
experiments. 
Figure 3. vFLIP IRES activity requires eIF4E. (A) Bicistronic capped mRNAs, CAT/vFLIP 
IRES/LUC or CAT/EMCV IRES/LUC, were translated in RRL in vitro in the presence of 0, 50 or 
250 M of the eIF4E inhibitor 4EGI-1 as indicated. (B) Bicistronic capped mRNAs, CAT/vFLIP 
IRES/LUC, were translated in RRL in vitro in the presence of 0, 10, 50 or 100 M of the eIF4E 
inhibitor 4E1RCat. (C) Bicistronic capped mRNAs, CAT/vFLIP IRES/LUC or CAT/EMCV 
IRES/LUC, were translated in RRL in vitro in the presence of 0, 50 or 500 M of the cap analogue.  
The CAT and LUC products are indicated. The data shown are representative from three 
independent experiments. 
Figure 4. vFLIP IRES forms an RNA-protein complex with eIFs. (A) Immunoblotting analysis of 
protein binding to the vFLIP IRES or an antisense control (vFLIP IRES_AS). Poly(A) tagged 
RNAs were immobilized onto oligo(dT) beads and following washes and elution, the proteins were 
separated by SDS-PAGE and analysed by immunoblotting against eIF4E and eIF4G. (B) 
Immunoblotting analysis of complexes assembled onto the vFLIP and HCV IRES. Hybrid RNA, 
containing the IRES fused to the tobramycin aptamer, were incubated with RRL pretreated with 
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puromycin, in the presence of GMPNP, then immobilized onto tobramycin-linked sepharose. RNA-
protein complexes were eluted in the presence of tobramycin and separated by SDS-PAGE, 
following immunoblotting analysis against rpS6, eIF4E, eIF4G and eIF3. A control lane of RRL 
was included as a reference for these factors.  
Figure 5. vFLIP IRES directly binds to 40S subunits and eIF3. (A) Binding curves of 32P-labeled 
CSFV and vFLIP IRES RNAs to purified human 40S subunits. Labeled RNAs were incubated with 
40S subunits and binding assessed by filter binding assay. (B) Binding curves of 32P-labeled CSFV 
and vFLIP IRES RNAs to purified human eIF3. Labeled RNAs were incubated with eIF3 and 
binding assessed by filter binding assay. (C) Binding curves of 32P-labeled EMCV and vFLIP IRES 
RNAs to purified human eIF4E and eIF4A/4G(p100) complex. Labeled RNAs were incubated with 
eIF4E and eIF4A/4G(p100) complex and binding assessed by filter binding assay. Reported values 
are the average from a minimum of three repetitions with standard errors. All calculations were 
performed with GraphPad Prism 7. (D) Immunoblotting analysis of protein binding to the vFLIP 
IRES or an antisense control (vFLIP IRES_AS). Poly(A) tagged RNAs were immobilized onto 
oligo(dT) beads and incubated with RRL treated with or without  2.5 g of recombinant FMDV L-
protease (L-pro) as indicated. Following washes and elution, the proteins were separated by SDS-
PAGE and analysed by immunoblotting against eIF4E and eIF4G as indicated. 
Figure 6. Secondary structure model of the vFLIP IRES. The mean SHAPE reactivity from three 
independent experiments is indicated for each position on the vFLIP IRES according to the colour 
code boxed. The chemical and enzymatic modifications induced by DMS, CMCT and RNAse V1 
are indicated using red circles, red diamonds and blue arrows, respectively. The names of the major 
domains determined are indicated on the model.  
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